Could fractional mRNA COVID-19 vaccines reduce myocarditis in adolescents?

Travel Med Infect Dis. 2021 Nov-Dec:44:102164. doi: 10.1016/j.tmaid.2021.102164. Epub 2021 Sep 14.

Authors

Luciana Albano¹, Pietro Ferrara²

Affiliations

¹ Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Via Luciano Armanni 5, I-80138, Naples, Italy.
² Center for Public Health Research, University of Milan - Bicocca, Via Cadore 48, I-20900, Monza, Italy. Electronic address: p.ferrara5@campus.unimib.it.

No abstract available

Publication types

Letter
Comment

MeSH terms

Adolescent
COVID-19 Vaccines
COVID-19*
Humans
Myocarditis* / prevention & control
RNA, Messenger
SARS-CoV-2

Substances

COVID-19 Vaccines
RNA, Messenger